Kimberley Ruxton

Kimberley Ruxton

Auto-generated profile, based on publicly available information

Kimberley Ruxton

Flinders University

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 May 2020 in Clinical Nutrition
Verified
Journal Article
Closed access
Nicola VeroneseNicola Veronese
Nicola Veronese
ACAlberto Cella
Alberto Cella
ACAlfonso J. Cruz-Jentoft
Alfonso J. Cruz-Jentoft
MMaria Cristina Polidori
Maria Cristina Polidori
FMFrancesco Mattace-Raso
Francesco Mattace-Raso
LFLuigi Ferrucci
Luigi Ferrucci

3 September 2016
Verified
Book Chapter
Closed access
PDF file
Arduino MangoniArduino Mangoni
Arduino Mangoni
KRKimberley Ruxton
Kimberley Ruxton
AMAnna Rachelle Mislang
Anna Rachelle Mislang
LBLaura Biganzoli
Laura Biganzoli

14 April 2016 in Geriatric Care
Verified
Journal Article
Open access
PDF file
Arduino MangoniArduino Mangoni
Arduino Mangoni
KRKimberley Ruxton
Kimberley Ruxton
Conventional end-points, primarily based on the pharmacodynamic effects of a specific drug, are used to assess the efficacy of pharmacological treatment in clinical trials. However, their application and interpretation in complex frail older patients, a patient group with high inter-individual variability, multiple coexisting disease states and prescribed medications, is becoming increasingly questionable. National surveys and qualitative studies have convincingly shown that the maintenance of functional independence is key to self-rated health and well being in old age. Therefore, the use of unconventional, patientcentered, end-points focused on functional status and perceived health seems appropriate, in combination with conventional end-points, to comprehensively investigate the impact of pharmacological treatments in this patient group. The recent availability of objective, quantifiable, and robust scoring tools, such as the multidimensional prognostic index, to assess key functional domains and clinical outcomes offers a unique opportunity to adequately characterize patient-centered endpoints in future clinical trials in older patients.